Mereo BioPharma Group Plc (MREO)
0.3066
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
0.30
-0.01
(-2.15%)
After-Hours: 19:59
Mereo BioPharma Group EPS Diluted (Quarterly) : -0.0364 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0364 |
| June 30, 2026 | -0.0437 |
| March 31, 2026 | -0.0418 |
| December 31, 2025 | -0.0461 |
| September 30, 2025 | -0.0436 |
| June 30, 2025 | -0.0925 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.0825 |
| December 31, 2024 | -0.045 |
| September 30, 2024 | -0.0984 |
| June 30, 2024 | -0.0862 |
| March 31, 2024 | -0.0639 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.007 |
| BioNTech SE | 0.8399 |
| Silence Therapeutics Plc | 0.00 |
| Autolus Therapeutics Plc | -0.2068 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.860M |
| Revenue (Quarterly) | 0.7996M |
| Total Expenses (Quarterly) | 6.660M |
| Enterprise Value | 23.19M |
| Gross Profit Margin (Quarterly) | 49.12% |
| Profit Margin (Quarterly) | -732.9% |
| Earnings Yield | -54.79% |
| Normalized Earnings Yield | -55.25 |